These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 8585204

  • 1. Some observations on D antigen expression of D-positive and 'weak D-positive' red cells as assessed by flow cytometry.
    Nelson M, Barrow LA, Popp H, Gibson J.
    Vox Sang; 1995; 69(2):152-4. PubMed ID: 8585204
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of monoclonal anti-Rh antibodies as reagents for blood grouping and for the identification of red cell membrane components associated with Rh antigen activity.
    Moore S, Green C, McGowan A.
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):141-4. PubMed ID: 3145542
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The determination of the Rh factor with anti-D monoclonal antibodies on a flat surface].
    Zavgorodniĭ GN, Pogodina TL, Pichugina MN.
    Gematol Transfuziol; 1993 Jan; 38(1):45-6. PubMed ID: 8020708
    [No Abstract] [Full Text] [Related]

  • 8. Weak D type 1.1 exemplifies another complexity in weak D genotyping.
    Doescher A, Flegel WA, Petershofen EK, Bauerfeind U, Wagner FF.
    Transfusion; 2005 Oct; 45(10):1568-73. PubMed ID: 16181206
    [Abstract] [Full Text] [Related]

  • 9. [Anti-Rho[D] antigen monoclonal antibodies. II. Serological characteristics of monoclonal IgG1 antibodies].
    Olovnikova NI, Belkina EV, Lemeneva LN, Berkovskiĭ AL, Deriugina EI, Chertkov IL.
    Gematol Transfuziol; 1992 Oct; 37(9-10):5-9. PubMed ID: 1490578
    [Abstract] [Full Text] [Related]

  • 10. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types.
    Körmöczi GF, Förstemann E, Gabriel C, Mayr WR, Schönitzer D, Gassner C.
    Transfusion; 2005 Oct; 45(10):1574-80. PubMed ID: 16181207
    [Abstract] [Full Text] [Related]

  • 11. More on the R0 Har antigenic complex.
    Case J.
    Transfusion; 1996 Oct; 36(11-12):1034-5. PubMed ID: 8937417
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serological studies of monoclonal RH antibodies with RH1 (D), RH2 (C), RH3 (E) and RH5 (e) variant RBCs.
    Noizat-Pirenne F, Ansart-Pirenne H, Ménanteau C, Braddock D, Rouzaud AM, Klein MT, Patereau C, Rouger P, Le Pennec PY.
    Transfus Clin Biol; 2003 Oct; 10(5):319-23. PubMed ID: 14572547
    [Abstract] [Full Text] [Related]

  • 18. Red blood cell alloimmunisation after platelet transfusion: a 5-year study.
    Moncharmont P, Barday G, Meyer F.
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s147-8. PubMed ID: 24120592
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.
    Sandler SG, Flegel WA, Westhoff CM, Denomme GA, Delaney M, Keller MA, Johnson ST, Katz L, Queenan JT, Vassallo RR, Simon CD, College of American Pathologists Transfusion Medicine Resource Committee Work Group.
    Transfusion; 2015 Mar; 55(3):680-9. PubMed ID: 25438646
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.